Abstract
Malignant hyperthermia (MH) is a severe hypermetabolic disorder associated with dysregulation of calcium homeostasis and is triggered by inhalational anesthetics (isoflurane, sevoflurane, desflurane) and a depolarizing muscle relaxant (succinylcholine). We report the case of a 16-day-old infant undergoing laparoscopic surgery. The patient developed hyperthermia and hypercarbia with muscle rigidity. After the diagnosis of MH, dantrolene was administered with sufficient hydration. The patient was transferred to the pediatric intensive care unit for monitoring and treatment of acute renal injury due to myoglobinuria. Subsequently, two variants of the ryanodine receptor 1 (RYR1) gene were identified in the patient as the mutation point at c.1589G > A p.Arg530His and c.1841G > T p.Arg614Leu, which are known to be associated with MH. This was a rare case of MH in a 16-day-old infant that might be related to two RYR1 mutations inherited from the parents.
Similar content being viewed by others
References
Visoiu M, Young MC, Wieland K, Brandom BW. Anesthetic drugs and onset of malignant hyperthermia. Anesth Analg. 2014;118:388–96.
Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015;10:93.
Brady JE, Sun LS, Rosenberg H, Li G. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001–2005. Anesth Analg. 2009;109:1162–6.
Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010;110:498–507.
Miyoshi H, Yasuda T, Otsuki S, Kondo T, Haraki T, Mukaida K, Nakamura R, Hamada H, Kawamoto M. Several ryanodine receptor type 1 gene mutations of p.Arg2508 are potential sources of malignant hyperthermia. Anesth Analg. 2015;121:994–1000.
Ibarra Moreno CA, Kraeva N, Zvaritch E, Figueroa L, Rios E, Biesecker L, Van Petegem F, Hopkins PM, Riazi S. A multi-dimensional analysis of genotype-phenotype discordance in malignant hyperthermia susceptibility. Br J Anaesth. 2020;125:995–1001.
Hopkins PM, Ruffert H, Snoeck MM, Girard T, Glahn KP, Ellis FR, Muller CR, Urwyler A, European Malignant Hyperthermia G. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth. 2015;115:531–9.
Ruffert H, Bastian B, Bendixen D, Girard T, Heiderich S, Hellblom A, Hopkins PM, Johannsen S, Snoeck MM, Urwyler A, Glahn KPE, European Malignant Hyperthermia G. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group. Br J Anaesth. 2021;126:120–30.
Glahn KPE, Bendixen D, Girard T, Hopkins PM, Johannsen S, Ruffert H, Snoeck MM, Urwyler A, European Malignant Hyperthermia G. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines. Br J Anaesth. 2020;125:133–40.
Podranski T, Bouillon T, Schumacher PM, Taguchi A, Sessler DI, Kurz A. Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work? Anesth Analg. 2005;101:1695–9.
Puschel K, Koops E, Schulz-Baldes JG. Postoperative malignant hyperthermia in a 7-day-old infant? Anaesthesist. 1989;38:81–4.
Stelzner J, Kretz FJ, Rieger A, Reinhart K. Anesthetic-induced heart arrest. A case report of 2 infants with previously unrecognized muscular dystrophy. Anaesthesist. 1993;42:44–6.
Kondo T, Yasuda T, Mukaida K, Otsuki S, Kanzaki R, Miyoshi H, Hamada H, Nishino I, Kawamoto M. Genetic and functional analysis of the RYR1 mutation p.Thr84Met revealed a susceptibility to malignant hyperthermia. J Anesth. 2018;32:174–81.
Otsuki S, Yasuda T, Mukaida K, Noda Y, Kanzaki R, Miyoshi H, Kondo T, Hamada H, Kawamoto M. Myotoxicity of local anesthetics is equivalent in individuals with and without predisposition to malignant hyperthermia. J Anesth. 2018;32:616–23.
Funding
This study did not receive any funding.
Author information
Authors and Affiliations
Contributions
YMT, this author helped conceive/design the case report, write/revise the manuscript, and with obtaining patients consent and analyzing the data. NK, this author helped with the anesthesia procedure, obtaining patients consent, data collection, and write/revise the manuscript. RK, this author helped with the anesthesia procedure and editing the manuscript. KT, this author helped with the anesthesia procedure and editing the manuscript. RK, this author helped with data collection, analyzing the data, and editing the manuscript. AM, this author helped with data collection and editing the manuscript. YN, this author helped with data collection and editing the manuscript. HM, this author helped with data collection and editing the manuscript. TK, this author helped with data collection and editing the manuscript. KM, this author helped conceive/design the case report, and with obtaining patients consent, analyzing the data, and editing the manuscript. All authors have read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tsutsumi, Y.M., Kakuta, N., Kawanishi, R. et al. Malignant hyperthermia in a 16-day-old infant with congenital diaphragmatic hernia: a case report. J Anesth 35, 311–314 (2021). https://doi.org/10.1007/s00540-021-02902-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-021-02902-2